{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:12:26Z","timestamp":1791997946812,"version":"4.4.0"},"reference-count":197,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Xeroderma Pigmentosum (XP) is a rare genetic syndrome with a defective DNA nucleotide excision repair. It is characterized by (i) an extreme sensitivity to ultraviolet (UV)-induced damages in the skin and eyes; (ii) high risk to develop multiple skin tumours; and (iii) neurologic alterations in the most severe form. To date, the management of XP patients consists of (i) early diagnosis; (ii) a long-life protection from ultraviolet radiation, including avoidance of unnecessary UV exposure, wearing UV blocking clothing, and use of topical sunscreens; and (iii) surgical resections of skin cancers. No curative treatment is available at present. Thus, in the last decade, in order to prevent or delay the progression of the clinical signs of XP, numerous strategies have been proposed and tested, in some cases, with adverse effects. The present review provides an overview of the molecular mechanisms featuring the development of XP and highlights both advantages and disadvantages of the clinical approaches developed throughout the years. The intention of the authors is to sensitize scientists to the crucial aspects of the pathology that could be differently targeted. In this context, the exploration of the process underlining the conception of liposomal nanocarriers is reported to focus the attention on the potentialities of liposomal technology to optimize the administration of chemoprotective agents in XP patients.<\/jats:p>","DOI":"10.3390\/jpm11111146","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T09:11:32Z","timestamp":1636017092000},"page":"1146","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Xeroderma Pigmentosum: General Aspects and Management"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5456-1960","authenticated-orcid":false,"given":"Monica","family":"Piccione","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5791-0775","authenticated-orcid":false,"given":"Anna","family":"Belloni Fortina","sequence":"additional","affiliation":[{"name":"Pediatric Dermatology Unit, Department of Medicine DIMED, University of Padova, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ferri","sequence":"additional","affiliation":[{"name":"I.R.A. Istituto Ricerche Applicate S.p.A., 20865 Usmate Velate, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Andolina","sequence":"additional","affiliation":[{"name":"I.R.A. Istituto Ricerche Applicate S.p.A., 20865 Usmate Velate, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Beretta","sequence":"additional","affiliation":[{"name":"I.R.A. Istituto Ricerche Applicate S.p.A., 20865 Usmate Velate, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cividini","sequence":"additional","affiliation":[{"name":"I.R.A. Istituto Ricerche Applicate S.p.A., 20865 Usmate Velate, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"De Marni","sequence":"additional","affiliation":[{"name":"I.R.A. Istituto Ricerche Applicate S.p.A., 20865 Usmate Velate, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3583-0816","authenticated-orcid":false,"given":"Francesca","family":"Caroppo","sequence":"additional","affiliation":[{"name":"Pediatric Dermatology Unit, Department of Medicine DIMED, University of Padova, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Citernesi","sequence":"additional","affiliation":[{"name":"I.R.A. Istituto Ricerche Applicate S.p.A., 20865 Usmate Velate, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7794-6804","authenticated-orcid":false,"given":"Rosa","family":"Di Liddo","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/jmg.2010.083022","article-title":"Cancer and neurologic degeneration in xeroderma pigmentosum: Long term follow-up characterises the role of DNA repair","volume":"48","author":"Bradford","year":"2011","journal-title":"J. Med. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/jid.2011.426","article-title":"Shining a Light on Xeroderma Pigmentosum","volume":"132","author":"DiGiovanna","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-04614-8","article-title":"Oxidative stress induced by UVA photoactivation of the tryptophan UVB photoproduct 6-formylindolo[3,2-b]carbazole (FICZ ) inhibits nucleotide excision repair in human cells","volume":"7","author":"Brem","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_4","unstructured":"(2021, September 10). Available online: http:\/\/www.orphadata.org\/cgi-bin\/index.php."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/carcin\/21.3.453","article-title":"Nucleotide excision repair and human syndromes","volume":"21","author":"Hoeijmakers","year":"2000","journal-title":"Carcinogenesis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/978-0-387-09599-8_2","article-title":"Clinical features of xeroderma pigmentosum","volume":"637","author":"Hengge","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1001\/archderm.1994.01690080084012","article-title":"The Role of Sunlight and DNA Repair in Melanoma and Nonmelanoma Skin Cancer-The Xeroderma Pigmentosum Paradigm","volume":"130","author":"Kraemer","year":"1994","journal-title":"Arch. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.4103\/ijo.IJO_1106_18","article-title":"Simultaneous squamous cell carcinoma and malignant melanoma of the conjunctiva in a teenager with xeroderma pigmentosum: Case report","volume":"67","author":"Caso","year":"2019","journal-title":"Indian J. Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"54","DOI":"10.33590\/emjdermatol\/10311902","article-title":"Xeroderma Pigmentosum: A Multidisciplinary Approach","volume":"1","author":"Sethi","year":"2013","journal-title":"EMJ Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12105-016-0707-8","article-title":"Xeroderma Pigmentosum","volume":"10","author":"Black","year":"2016","journal-title":"Head Neck Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.annder.2018.09.004","article-title":"Xeroderma pigmentosum","volume":"145","author":"Zghal","year":"2018","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_12","first-page":"143","article-title":"The genetic basis of xeroderma pigmentosum","volume":"34","author":"Bootsma","year":"1991","journal-title":"Ann. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2133.1992.tb00681.x","article-title":"A child with xeroderma pigmentosum and bone marrow failure","volume":"126","author":"Salob","year":"1992","journal-title":"Br. J. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8988","DOI":"10.3390\/ijms16048988","article-title":"Xeroderma pigmentosum: Low prevalence of germline XPA mutations in a brazilian XP population","volume":"16","author":"Santiago","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/brain\/113.4.1025","article-title":"Peripheral neuropathy in xeroderma pigmentosum","volume":"113","author":"Kanda","year":"1990","journal-title":"Brain"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/humu.20392","article-title":"Phenotypic Heterogeneity in the XPB DNA Helicase Gene (ERCC3): Xeroderma Pigmentosum Without and with Cockayne Syndrome","volume":"27","author":"Oh","year":"2006","journal-title":"Hum. Mutat."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-80-2-221","article-title":"Xeroderma Pigmentosum An Inherited Disease with Sun Sensitivity, Multiple Cutaneous Neoplasms, and Abnormal DNA Repair","volume":"80","author":"Robbins","year":"1974","journal-title":"Ann. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/1346-8138.13907","article-title":"Xeroderma pigmentosum clinical practice guidelines","volume":"44","author":"Moriwaki","year":"2017","journal-title":"J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0190-9622(93)70263-S","article-title":"Xeroderma pigmentosum-Cockayne syndrome complex in two patients: Absence of slun tumors despite severe deficiency of DNA excision repair","volume":"29","author":"Scott","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/bjd.12183","article-title":"Unexpected extradermatological findings in 31 patients with xeroderma pigmentosum type C","volume":"168","author":"Oriot","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1523-1747.2001.01424.x","article-title":"A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: Molecular genetic evidence for a common ancestor","volume":"117","author":"Gozukara","year":"2001","journal-title":"J. Investig. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archderm.1984.01650380035006","article-title":"Xeroderma pigmentosum: Complementation group C and malignant melanoma","volume":"120","author":"Lynch","year":"1984","journal-title":"Arch. Derm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/hmg\/ddh026","article-title":"Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene: Mutations results in reduced XPC mRNA levels that correlate with cancre risk","volume":"13","author":"Khan","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_24","first-page":"1974","article-title":"Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels","volume":"60","author":"Chavanne","year":"2000","journal-title":"Cancer Res."},{"key":"ref_25","unstructured":"The UniProt Consortium (2021, September 10). Disease-Xeroderma Pigmentosum Complementation Group D. Available online: https:\/\/www.uniprot.org\/diseases\/1158."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1600-0625.2012.01446.x","article-title":"Xeroderma pigmentosum complementation group G patient with a novel homozygous missense mutation and no neurological abnormalities","volume":"21","author":"Moriwaki","year":"2012","journal-title":"Exp. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0921-8777(92)90072-B","article-title":"The XPD complementation group: Insights into xeroderma pigmentosum, Cockayne\u2019s syndrome and trichothiodystrophy","volume":"273","author":"Johnson","year":"1992","journal-title":"Mutat. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1126\/science.3175673","article-title":"Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA","volume":"242","author":"Chu","year":"1988","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0190-9622(88)70121-8","article-title":"Xeroderma pigmentosum complementation group F in a non-Japanese patient","volume":"18","author":"Norris","year":"1988","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2133.1989.tb15514.x","article-title":"Clinical and photobiological characteristics of xeroderma pigmentosum complementation group F: A review of cases from Japan","volume":"121","author":"Yamamura","year":"1989","journal-title":"Br. J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2133.1978.tb15252.x","article-title":"Xeroderma pigmentosum\u2013\u2013A unique variant with neurological involvement","volume":"99","author":"Chessbrough","year":"1978","journal-title":"Br. J. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1203\/00006450-200103000-00016","article-title":"Xeroderma pigmentosum group G with severe neurological involvement and features of Cockayne syndrome in infancy","volume":"49","author":"Zafeiriou","year":"2001","journal-title":"Pediatr. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/php.12385","article-title":"Development of effective skin cancer treatment and prevention in xeroderma pigmentosum","volume":"91","author":"Lambert","year":"2015","journal-title":"Photochem. Photobiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4818162","DOI":"10.1155\/2019\/4818162","article-title":"Xeroderma Pigmentosum: Ocular Findings in an Isolated Brazilian Group with an Identified Genetic Cluster","volume":"2019","author":"Schelini","year":"2019","journal-title":"J. Ophthalmol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/archdermatol.2009.303","article-title":"Factors That Affect Skin Aging","volume":"145","author":"Martires","year":"2009","journal-title":"Arch. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2019.00759","article-title":"Environmental Stressors on Skin Aging. Mechanistic Insights","volume":"10","author":"Parrado","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.taap.2003.09.028","article-title":"Solar ultraviolet radiation as a trigger of cell signal transduction","volume":"195","author":"Heck","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.3390\/ijms140612222","article-title":"UV radiation and the skin","volume":"14","author":"Jarrett","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.3390\/ijms14036414","article-title":"Molecular Mechanisms of UV-Induced Apoptosis and Its Effects on Skin Residential Cells: The Implication in UV-Based Phototherapy","volume":"14","author":"Lee","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_40","first-page":"3410","article-title":"Clinicopathological characteristics of xeroderma pigmentosum associated with keratoacanthoma: A case report and literature review","volume":"7","author":"Zheng","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/DAD.0b013e3181af0a5e","article-title":"Diagnosing Xeroderma pigmentosum group C by immunohistochemistry","volume":"32","author":"Fraitag","year":"2010","journal-title":"Am. J. Dermatopathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.4161\/cc.7.14.6326","article-title":"A wide-ranging cellular response to UV damage of DNA","volume":"7","author":"Stokes","year":"2008","journal-title":"Cell Cycle"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1093\/nar\/gkg675","article-title":"Cell cycle arrest and apoptosis provoked by UV radiation-induced DNA damage are transcriptionally highly divergent responses","volume":"31","author":"Gentile","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"15588","DOI":"10.1074\/jbc.R117.807453","article-title":"Molecular mechanisms and genomic maps of DNA excision repair in Escherichia coli and humans","volume":"292","author":"Hu","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/cr040483f","article-title":"Molecular mechanisms of mammalian global genome nucleotide excision repair","volume":"106","author":"Gillet","year":"2006","journal-title":"Chem. Rev."},{"key":"ref_46","unstructured":"Friedberg, E.C., Roger, A.S., Wolfram, S., Graham, C.W., Tom, E., and Richard, D.W. (2006). DNA Repair and Mutagenesis, ASM Press. [2nd ed.]. Available online: https:\/\/books.google.it\/books\/about\/DNA_Repair_and_Mutagenesis.html?id=xVmZKUie2lkC&redir_esc=y."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1039\/c2pp25267h","article-title":"Spotlight on \u2019xeroderma pigmentosum\u2019","volume":"12","author":"Fassihi","year":"2013","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mrrev.2009.12.001","article-title":"Dealing with DNA damage: Relationships between checkpoint and repair pathways","volume":"704","author":"Warmerdam","year":"2010","journal-title":"Mutat. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.dnarep.2018.08.005","article-title":"Molecular basis for damage recognition and verification by XPC-RAD23B and TFIIH in nucleotide excision repair","volume":"71","author":"Mu","year":"2018","journal-title":"DNA Repair (Amst)"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41021-019-0119-6","article-title":"Mechanism and regulation of DNA damage recognition in mammalian nucleotide excision repair","volume":"41","author":"Kusakabe","year":"2019","journal-title":"Genes Environ."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1093\/nar\/gkq649","article-title":"Localization of xeroderma pigmentosum group A protein and replication protein A on damaged DNA in nucleotide excision repair","volume":"38","author":"Krasikova","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_52","first-page":"139","article-title":"XPA: A key scaffold for human NER","volume":"176","author":"Sugitani","year":"2016","journal-title":"DNA Repair"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/s41467-020-15168-1","article-title":"Single molecule analysis reveals monomeric XPA bends DNA and undergoes episodic linear diffusion during damage search","volume":"11","author":"Beckwitt","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/jid.2014.161","article-title":"UV signaling pathways within the skin","volume":"134","author":"Chen","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1038\/sj.emboj.7601894","article-title":"Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA","volume":"26","author":"Tsodikov","year":"2007","journal-title":"EMBO J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.dnarep.2011.04.022","article-title":"Regulation of endonuclease activity in human nucleotide excision repair","volume":"10","author":"Fagbemi","year":"2011","journal-title":"DNA Repair (Amst)"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"22889","DOI":"10.1074\/jbc.M112.374447","article-title":"Mechanism of release and fate of excised oligonucleotides during nucleotide excision repair","volume":"287","author":"Kemp","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Krasikova, Y., Rechkunova, N., and Lavrik, O. (2021). Nucleotide excision repair: From molecular defects to neurological abnormalities. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126220"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a012609","article-title":"Nucleotide Excision Repair in Eukaryotes","volume":"5","author":"Scharer","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jdermsci.2018.03.009","article-title":"UV-induced DNA methyltransferase 1 promotes hypermethylation of tissue inhibitor of metalloproteinase 2 in the human skin","volume":"91","author":"Kim","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Zhu, J.W., Wu, X.J., Lu, Z.F., Luo, D., Cai, S.Q., and Zheng, M. (2013). Role of VEGF Receptors in Normal and Psoriatic Human Keratinocytes: Evidence from Irradiation with Different UV Sources. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055463"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/PL00000265","article-title":"UV radiation and prostaglandin E2 up-regulate vascular endothelial growth factor (VEGF) in cultured human fibroblasts","volume":"50","author":"Trompezinski","year":"2001","journal-title":"Inflamm. Res."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Xu, H., Zheng, Y.W., Liu, Q., Liu, L.P., Luo, F.L., Zhou, H.C., Isoda, H., Ohkohchi, N., and Li, Y.M. (2017). Reactive Oxygen Species in Skin Repair, Regeneration, Aging, and Inflammation. Reactive Oxygen Species (ROS) in Living Cells, IntechOpen.","DOI":"10.5772\/intechopen.72747"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.18632\/oncotarget.7595","article-title":"Ultraviolet radiation-induced tumor necrosis factor alpha, which is linked to the development of cutaneous SCC, modulates differential epidermal microRNAs expression","volume":"7","author":"Singh","year":"2016","journal-title":"Oncotarget"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/sj.onc.1204383","article-title":"AP-1 in cell proliferation and survival","volume":"20","author":"Shaulian","year":"2001","journal-title":"Oncogene"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/php.13245","article-title":"Deciphering UV-induced DNA responses to prevent and treat skin cancer","volume":"96","author":"Lee","year":"2020","journal-title":"Photochem. Photobiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1038\/onc.2015.524","article-title":"Caspases uncouple p27Kip1 from cell cycle regulated degradation and abolish its ability to stimulate cell migration and invasion","volume":"35","author":"Podmirseg","year":"2016","journal-title":"Oncogene"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_69","first-page":"2615","article-title":"Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review)","volume":"41","author":"Frassanito","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_70","first-page":"602","article-title":"Ultraviolet-B Radiation Causes an Upregulation of Survivin in Human Keratinocytes and Mouse Skin","volume":"80","author":"Ghotra","year":"2004","journal-title":"Photochem. Photobiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.taap.2003.08.019","article-title":"Toxic effects of ultraviolet radiation on the skin","volume":"195","author":"Matsumura","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1039\/b504573h","article-title":"Endogenous UVA-photosensitizers: Mediators of skin photodamage and novel targets for skin photoprotection","volume":"5","author":"Wondrak","year":"2006","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mrfmmm.2004.06.057","article-title":"Mutations induced by ultraviolet light","volume":"571","author":"Pfeifer","year":"2005","journal-title":"Mutat. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"44688","DOI":"10.1074\/jbc.M107696200","article-title":"Cyclobutane Pyrimidine Dimers Are Responsible for the Vast Majority of Mutations Induced by UVB Irradiation in Mammalian Cells","volume":"276","author":"You","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1751-1097.1989.tb05578.x","article-title":"The biology of the (6-4) photoproduct","volume":"49","author":"Mitchell","year":"1989","journal-title":"Photochem. Photobiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"20321","DOI":"10.3390\/ijms151120321","article-title":"Structural biology of DNA (6-4) photoproducts formed by ultraviolet radiation and interactions with their binding proteins","volume":"15","author":"Yokoyama","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.1256022","article-title":"Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure","volume":"347","author":"Premi","year":"2015","journal-title":"Science"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1011-1344(01)00245-7","article-title":"Biological consequences of cyclobutane pyrimidine dimers","volume":"65","author":"Vink","year":"2001","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1523-1747.1998.00324.x","article-title":"Thymidine dinucleotides induce S phase cell cycle arrest in addition to increased melanogenesis in human melanocytes","volume":"111","author":"Pedeux","year":"1998","journal-title":"J. Investig. Dermatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1172\/JCI9745","article-title":"A role for NF-\u03baB-dependent gene transactivation in sunburn","volume":"105","author":"Abeyama","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s13671-020-00288-0","article-title":"Photoaging: A Review of Current Literature","volume":"9","author":"Huang","year":"2020","journal-title":"Curr. Dermatol. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4161\/derm.19858","article-title":"Environmental influences on skin aging and ethnic-specific manifestations","volume":"4","author":"Krutmann","year":"2012","journal-title":"Dermatoendocrinology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/ars.2012.4938","article-title":"New insights into the link between DNA damage and apoptosis","volume":"19","author":"Cianfanelli","year":"2013","journal-title":"Antioxidants Redox Signal."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2147\/CCID.S220741","article-title":"Six critical questions for DNA repair enzymes in skincare products: A review in dialog","volume":"12","author":"Yarosh","year":"2019","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_85","first-page":"142","article-title":"Protein kinases and transcription factors activation in response to UV-radiation of skin: Implications for carcinogenesis","volume":"13","author":"Ocampo","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"26732","DOI":"10.1016\/S0021-9258(19)61437-7","article-title":"Distribution and Repair of Bipyrimidine Photoproducts in Solar UV-irradiated Mammalian Cells","volume":"275","author":"Perdiz","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_87","first-page":"102","article-title":"Cyclobutane pyrimidine dimers are the main mutagenic DNA photoproducts in DNA repair-deficient trichothiodystrophy cells","volume":"58","author":"Marionnet","year":"1998","journal-title":"Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-319-56017-5_2","article-title":"Ultraviolet Light Induced Generation of Reactive Oxygen Species","volume":"996","author":"Cockrell","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1473-2165.2012.00614.x","article-title":"Effects of solar radiation on the skin","volume":"11","author":"Polefka","year":"2012","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1042\/BJ20151227","article-title":"Protein oxidation and peroxidation","volume":"473","author":"Davies","year":"2016","journal-title":"Biochem. J."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaad.2017.09.012","article-title":"Age-induced and photoinduced changes in gene expression profiles in facial skin of Caucasian females across 6 decades of age","volume":"78","author":"Kimball","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_92","first-page":"518","article-title":"Therapeutic Response of a Brother and Sister with Xeroderma Pigmentosum to Imiquimod 5% Cream","volume":"28","author":"Weisberg","year":"2002","journal-title":"Dermatol. Surg."},{"key":"ref_93","unstructured":"Kugler, M. (2021, September 10). Xeroderma Pigmentosum Disease Symptoms and Treatment. Available online: https:\/\/www.verywellhealth.com\/xeroderma-pigmentosum-2861056."},{"key":"ref_94","first-page":"16","article-title":"Sunscreening agents: A review","volume":"6","author":"Latha","year":"2013","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_95","unstructured":"Gabros, S., Nessel, T., and Zito, P. (2021, September 10). Sunscreens and Photoprotection, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537164\/."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/DER.0000000000000079","article-title":"Adverse reactions to sunscreen agents: Epidemiology, responsible irritants and allergens, clinical characteristics, and management","volume":"25","author":"Heurung","year":"2014","journal-title":"Dermatitis"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.dnarep.2011.04.027","article-title":"Xeroderma pigmentosum family support group: Helping families and promoting clinical initiatives","volume":"10","author":"Milota","year":"2011","journal-title":"DNA Repair (Amst)"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/phpp.12108","article-title":"Living with xeroderma pigmentosum: Comprehensive photoprotection for highly photosensitive patients","volume":"30","author":"Tamura","year":"2014","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2605.2012.01280.x","article-title":"Sunscreens: Are they beneficial for health? An overview of endocrine disrupting properties of UV-filters","volume":"35","author":"Krause","year":"2012","journal-title":"Int. J. Androl."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"867.e1","DOI":"10.1016\/j.jaad.2013.08.022","article-title":"Photoprotection: Part II. Sunscreen: Development, efficacy, and controversies","volume":"69","author":"Jansen","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s40257-017-0290-0","article-title":"Sunscreens: An update","volume":"18","author":"Maruthi","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/NSA.S19419","article-title":"Titanium dioxide and zinc oxide nanoparticles in sunscreens: Focus on their safety and effectiveness","volume":"4","author":"Smijs","year":"2011","journal-title":"Nanotechnol. Sci. Appl."},{"key":"ref_103","first-page":"98","article-title":"Photoprotection: Facts and controversies","volume":"19","author":"Skotarczak","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1067\/mjd.2001.113685","article-title":"Mechanisms of sunscreen failure","volume":"44","author":"Wright","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/1203475419856611","article-title":"Sunscreen Application, Safety, and Sun Protection: The Evidence","volume":"23","author":"Li","year":"2019","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_106","unstructured":"(2021, September 10). Directorate-European Commission Health & Consumer. Opinion on Benzophenone-3. COLIPA N\u00b0 S38. Available online: https:\/\/ec.europa.eu\/health\/ph_risk\/committees\/04_sccp\/docs\/sccp_o_159.pdf."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/jocd.12449","article-title":"Dermatological and environmental toxicological impact of the sunscreen ingredient oxybenzone\/benzophenone-3","volume":"17","author":"DiNardo","year":"2018","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_108","first-page":"512","article-title":"Topical Treatment of Xeroderma Pigmentosum","volume":"29","author":"Lin","year":"2004","journal-title":"Pharm. Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2165\/00128071-200304070-00003","article-title":"Dermabrasion in dermatology","volume":"4","author":"Gold","year":"2003","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0007-1226(92)90059-7","article-title":"Xeroderma Pigmentosum: Resurfacing versus dermabrasion","volume":"45","author":"Agrawal","year":"1992","journal-title":"Br. J. Plast. Surg."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1076-0512(96)00431-1","article-title":"Dermabrasion in xeroderma pigmentosum","volume":"22","author":"Field","year":"1996","journal-title":"Dermatol. Surg."},{"key":"ref_112","first-page":"732","article-title":"Chemical Peeling in the Treatment of Xeroderma Pigmentosum","volume":"12","author":"Alzacko","year":"2013","journal-title":"Iraqi Prostgrad. Med. J."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/00006534-199904020-00016","article-title":"Facial resurfacing in xeroderma pigmentosum with chemical peeling","volume":"103","author":"Wee","year":"1999","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e2250","DOI":"10.1097\/GOX.0000000000002250","article-title":"Jessner\u2019s Solution with Trichloroacetic Acid Chemical Peel: Optimizing Outcomes and Safety","volume":"7","author":"Dayan","year":"2019","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0190-9622(95)90348-8","article-title":"The role of dermabrasion and chemical peels in the treatment of patients with xeroderma pigmentosum","volume":"32","author":"Nelson","year":"1995","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/BF01965758","article-title":"Retinoic acid: Topical treatment of senile or actinic keratoses and basal cell carcinomas","volume":"1","author":"Bollag","year":"1970","journal-title":"Agents Actions"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"427285","DOI":"10.4061\/2011\/427285","article-title":"Beneficial regulation of matrix metalloproteinases for skin health","volume":"2011","author":"Philips","year":"2011","journal-title":"Enzym. Res."},{"key":"ref_118","first-page":"435","article-title":"Systemic and topical drugs for aging skin","volume":"2","author":"Kockaert","year":"2003","journal-title":"J. Drugs Dermatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1590\/abd1806-4841.20131803","article-title":"Retinoids for prevention and treatment of actinic keratosis","volume":"88","author":"Ianhez","year":"2013","journal-title":"An. Bras. Dermatol."},{"key":"ref_120","first-page":"656","article-title":"Systemic and Topical Retinoids in the Management of Skin Cancer in Organ Transplant Recipients","volume":"30","author":"Euvrard","year":"2004","journal-title":"Dermatol. Surg."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.abd.2020.09.001","article-title":"Consensus on the use of oral isotretinoin in dermatology-Brazilian Society of Dermatology","volume":"95","author":"Bagatin","year":"2020","journal-title":"An. Bras. Dermatol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0733-8635(05)70237-0","article-title":"Systemic retinoid therapy","volume":"19","author":"DiGiovanna","year":"2001","journal-title":"Dermatol. Clin."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00403-006-0638-4","article-title":"Effects of isotretinoin on the metabolism of triglyceride-rich lipoproteins and on the lipid profile in patients with acne","volume":"297","author":"Brandizzi","year":"2006","journal-title":"Arch. Dermatol. Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0738-081X(01)00170-5","article-title":"Laser and Photodynamic Therapy in the Management of Cutaneous Malignancies","volume":"19","author":"Zeitouni","year":"2001","journal-title":"Clin. Dermatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/21678707.2017.1256770","article-title":"Genetic therapy of Xeroderma Pigmentosum: Analysis of strategies and translation","volume":"5","author":"Magnaldo","year":"2017","journal-title":"Expert Opin. Orphan Drugs"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/01.iop.0000246600.80517.d3","article-title":"Aggravation of Eyelid and Conjunctival Malignancies Following Photodynamic Therapy in DeSanctis- Cacchione Syndrome","volume":"22","author":"Procianoy","year":"2006","journal-title":"Ophthal. Plast. Reconstr. Surg."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/1523-1747.ep12612828","article-title":"Sunscreens and T4N5 liposomes differ in their ability to protect against ultraviolet-induced sunburn cell formation, alterations of dendritic epidermal cells, and local suppression of contact hypersensitivity","volume":"104","author":"Wolf","year":"1995","journal-title":"J. Investig. Dermatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1525-1470.2011.01657.x","article-title":"Photodynamic Therapy in a Teenage Girl with Xeroderma Pigmentosum Type C","volume":"29","author":"Larson","year":"2012","journal-title":"Pediatr. Dermatol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"101761","DOI":"10.1016\/j.pdpdt.2020.101761","article-title":"Photodynamic therapy in the treatment of xeroderma pigmentosum: A case report","volume":"30","author":"Cai","year":"2020","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_130","unstructured":"Goldberg, D.J. (2021, September 10). Ablative Laser Resurfacing for Skin Rejuvenation, Available online: https:\/\/www.uptodate.com\/contents\/ablative-laser-resurfacing-for-skin-rejuvenation."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0733-8635(03)00053-6","article-title":"Laser treatment of epidermal and dermal lesions","volume":"20","author":"Hruza","year":"2002","journal-title":"Dermatol. Clin."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5978\/islsm.14-RE-01","article-title":"The Role of the CO2 Laser and Fractional CO2 Laser in Dermatology","volume":"23","author":"Omi","year":"2014","journal-title":"Laser Ther."},{"key":"ref_133","first-page":"763","article-title":"Use of laser in treatment of premalignant skin conditions","volume":"15","author":"Shabba","year":"2018","journal-title":"Pak. J. Biotechnol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0733-8635(05)70286-2","article-title":"Erbium:YAG cutaneous laser resurfacing","volume":"19","author":"Alster","year":"2001","journal-title":"Dermatol. Clin."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/archderm.135.4.444","article-title":"Why does carbon dioxide resurfacing work? A review","volume":"135","author":"Ross","year":"1999","journal-title":"Arch. Dermatol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/lsm.20012","article-title":"Full Face Laser Resurfacing: Therapy and Prophylaxis for Actinic Keratoses and Non-Melanoma Skin Cancer","volume":"34","author":"Iyer","year":"2004","journal-title":"Lasers Surg. Med."},{"key":"ref_137","first-page":"261","article-title":"Recurrence rates and long-term follow-up after laser resurfacing as a treatment for widespread actinic keratoses in the face and on the scalp","volume":"32","author":"Ostertag","year":"2006","journal-title":"Dermatol. Surg."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-Fluorouracil: Mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/molecules13081551","article-title":"5-Fluorouracil: Mechanisms of resistance and reversal strategies","volume":"13","author":"Zhang","year":"2008","journal-title":"Molecules"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2310\/7750.2008.07045","article-title":"Open-label study to assess the safety and efficacy of imiquimod 5% cream applied once daily three times per week in cycles for treatment of actinic keratoses on the head","volume":"12","author":"Rivers","year":"2008","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaad.2003.12.010","article-title":"Imiquimod 5% cream for the treatment of actinic keratosis: Results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials","volume":"50","author":"Lebwohl","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.141.4.467","article-title":"Dosing With 5% Imiquimod Cream 3 Times per Week for the Treatment of Actinic Keratosis","volume":"141","author":"Korman","year":"2005","journal-title":"Arch. Dermatol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jaad.2004.02.022","article-title":"Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology","volume":"51","author":"Szeimies","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00042728-200506000-00008","article-title":"Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream","volume":"31","author":"Lee","year":"2005","journal-title":"Dermatol. Surg."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2230.28.s1.10.x","article-title":"The treatment of basal skin carcinomas in two sisters with xeroderma pigmentosum","volume":"28","author":"Roseeuw","year":"2003","journal-title":"Clin. Exp. Dermatol. Suppl."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1525-1470.2012.01780.x","article-title":"Psoriasiform eruption and oral ulcerations as adverse effects of topical 5% imiquimod treatment in children: A report of four cases","volume":"30","author":"Smith","year":"2013","journal-title":"Pediatr. Dermatol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e13116","DOI":"10.1111\/dth.13116","article-title":"Imiquimod cream in pediatric patients: Recommendations, adverse events, and controversies","volume":"32","author":"Dika","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1089\/hum.1995.6.10-1307","article-title":"Functional Retroviral Vector for Gene Therapy of Xeroderma Pigmentosum Group D Patients","volume":"1315","author":"Carreau","year":"1995","journal-title":"Hum. Gene Ther."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/sj.gt.3300495","article-title":"Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C","volume":"4","author":"Zeng","year":"1997","journal-title":"Gene Ther."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1023\/A:1007477820594","article-title":"Retrovirus-mediated DNA repair gene transfer into xeroderma pigmentosum cells: Perspectives for a gene therapy","volume":"14","author":"Zeng","year":"1998","journal-title":"Cell Biol. Toxicol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1089\/hum.1994.5.10-1241","article-title":"Systemic delivery of secreted protein by grafts of epidermal keratinocytes: Prospects for keratinocyte gene therapy","volume":"5","author":"Fenjves","year":"1994","journal-title":"Hum. Gene Ther."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/mt.2011.233","article-title":"Preclinical corrective gene transfer in xeroderma pigmentosum human skin stem cells","volume":"20","author":"Warrick","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/156652307780859017","article-title":"On the Search for Skin Gene Therapy Strategies of Xeroderma Pigmentosum Disease","volume":"7","author":"Menck","year":"2007","journal-title":"Curr. Gene Ther."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0078678","article-title":"Targeted Gene Therapy of Xeroderma Pigmentosum Cells Using Meganuclease and Talen","volume":"8","author":"Dupuy","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1093\/nar\/gkg375","article-title":"A novel engineered meganuclease induces homologous recombination in yeast and mammalian cells","volume":"31","author":"Epinat","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/bies.201300135","article-title":"Exploiting CRISPR\/Cas systems for biotechnology","volume":"36","author":"Sampson","year":"2014","journal-title":"BioEssays"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1093\/hmg\/ddu125","article-title":"CRISPR\/Cas9 for genome editing: Progress, implications and challenges","volume":"23","author":"Zhang","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mrfmmm.2014.08.007","article-title":"DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease","volume":"776","author":"Dupuy","year":"2015","journal-title":"Mutat. Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000079993","article-title":"Xeroderma pigmentosum: From Symptoms and Genetics to Gene-Based Skin Therapy","volume":"177","author":"Magnaldo","year":"2004","journal-title":"Cell Tissues Organs"},{"key":"ref_160","first-page":"405","article-title":"Repairing DNA damage in xeroderma pigmentosum: T4N5 lotion and gene therapy","volume":"7","author":"Zahid","year":"2008","journal-title":"J. Drugs Dermatol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1248\/bpb.b16-00624","article-title":"Liposomal Delivery Systems: Design Optimization and Current Applications","volume":"40","author":"Ishida","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"ref_162","first-page":"297","article-title":"Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int. J. Nanomed."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as nanomedical devices","volume":"10","author":"Bozzuto","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2174\/0929867324666171009120154","article-title":"Recent Advances and Perspectives in Liposomes for Cutaneous Drug Delivery","volume":"25","author":"Carita","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"113642","DOI":"10.1016\/j.jpba.2020.113642","article-title":"Analytical characterization of liposomes and other lipid nanoparticles for drug delivery","volume":"192","author":"Fan","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jconrel.2016.01.039","article-title":"Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity","volume":"225","author":"Patil","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1007\/s00216-017-0527-z","article-title":"Zeta potential: A case study of cationic, anionic, and neutral liposomes","volume":"409","author":"Smith","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1213\/01.ane.0000265533.13477.26","article-title":"Single-dose, extended-release epidural morphine (DepoDurTM) compared to conventional epidural morphine for post-Cesarean pain","volume":"105","author":"Carvalho","year":"2007","journal-title":"Anesth. Analg."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1016\/S0264-410X(03)00509-7","article-title":"Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal\u00ae)","volume":"21","author":"Usonis","year":"2003","journal-title":"Vaccine"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0264-410X(02)00512-1","article-title":"Inflexal\u00aeV a trivalent virosome subunit influenza vaccine: Production","volume":"20","author":"Mischler","year":"2002","journal-title":"Vaccine"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/wnan.1450","article-title":"Stimuli-responsive liposomes for drug delivery","volume":"9","author":"Lee","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/1040-8428(92)90056-V","article-title":"Liposomes in the treatment of malignancy: A clinical perspective","volume":"12","author":"Sugarman","year":"1992","journal-title":"Crit Rev. Oncol. Hematol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1080\/21691401.2017.1290647","article-title":"Liposome-targeted delivery for highly potent drugs","volume":"45","author":"Bardania","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40265-021-01480-7","article-title":"BNT162b2 mRNA COVID-19 Vaccine: First Approval","volume":"81","author":"Lamb","year":"2021","journal-title":"Drugs"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1080\/21691401.2017.1282496","article-title":"Recent advances on liposomal nanoparticles: Synthesis, characterization and biomedical applications","volume":"45","author":"Panahi","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0781.1995.tb00130.x","article-title":"Reduction of ultraviolet-induced skin cancer in mice by topical application of DNA excision repair enzymes","volume":"11","author":"Bito","year":"1995","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0921-8777(89)90011-6","article-title":"Structure-function studies of the T4 endonuclease V repair enzyme","volume":"218","author":"Dodson","year":"1989","journal-title":"Mutat. Res. Repair"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1073\/pnas.74.7.2958","article-title":"Specific action of T4 endonuclease V on damaged DNA in xeroderma pigmentosum cells in vivo","volume":"74","author":"Tanaka","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1074\/jbc.270.8.3765","article-title":"T4 endonuclease V protects the DNA strand opposite a thymine dimer from cleavage by the footprinting reagents DNase I and 1,10-phenanthroline-copper","volume":"270","author":"Latham","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1073\/pnas.72.10.4071","article-title":"Restoration of ultraviolet-induced unscheduled DNA synthesis of xeroderma pigmentosum cells by the concomitant treatment with bacteriophage T4 endonuclease V and HVJ (Sendai virus)","volume":"72","author":"Tanaka","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/1523-1747.ep12277569","article-title":"Encapsulation of the UV-DNA Repair Enzyme T4 Endonuclease V in Liposomes and Delivery to Human Cells","volume":"93","author":"Ceccoli","year":"1989","journal-title":"Soc. Investig. Dermatol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/1523-1747.ep12371673","article-title":"Treatment of human melanocytes and S91 melanoma cells with the DNA repair enzyme T4 endonuclease V enhances melanogenesis after ultraviolet irradiation","volume":"101","author":"Gilchrest","year":"1993","journal-title":"J. Investig. Dermatol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/1523-1747.ep12479314","article-title":"Enhanced unscheduled DNA synthesis in UV-irradiated human skin explants treated with T4N5 liposomes","volume":"97","author":"Yarosh","year":"1991","journal-title":"J. Investig. Dermatol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/1523-1747.ep12395551","article-title":"Localization of liposomes containing a DNA repair enzyme in murine skin","volume":"103","author":"Yarosh","year":"1994","journal-title":"J. Investig. Dermatol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1039\/b504068j","article-title":"Cyclobutane pyrimidine dimer formation is a molecular trigger for solar-simulated ultraviolet radiation-induced suppression of memory immunity in humans","volume":"4","author":"Kuchel","year":"2005","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1517\/14712598.8.6.829","article-title":"T4 endonuclease V: Review and application to dermatology","volume":"8","author":"Cafardi","year":"2008","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_187","first-page":"136","article-title":"Photoprotection by Topical DNA Repair Enzymes: Molecular Correlates of Clinical Studies","volume":"69","author":"Yarosh","year":"1999","journal-title":"Photochem. Photobiol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(00)04214-8","article-title":"Early report Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: A randomised study","volume":"357","author":"Yarosh","year":"2001","journal-title":"Lancet"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejmech.2019.01.007","article-title":"Composition design and medical application of liposomes","volume":"164","author":"Li","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.sder.2011.01.003","article-title":"New Agents for Prevention of Ultraviolet-Induced Nonmelanoma Skin Cancer","volume":"30","author":"Camp","year":"2011","journal-title":"Semin. Cutan. Med. Surg."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/13543784.2019.1636030","article-title":"Investigational drugs currently in phase II clinical trials for actinic keratosis","volume":"28","author":"Lozzi","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_192","unstructured":"ClinicalTrials (2021, September 10). T4N5 Liposomal Lotion in Preventing the Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00089180?term=dimericine&draw=2&rank=1."},{"key":"ref_193","unstructured":"ClinicalTrials (2021, September 10). T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT00002811?term=dimericine&draw=2&rank=2."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"176","DOI":"10.25259\/IJDVL_431_19","article-title":"Therapeutics of xeroderma pigmentosum: A PRISMA-compliant systematic review","volume":"87","author":"Isoldi","year":"2021","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1755-148X.2009.00643.x","article-title":"Enhancement of DNA repair using topical T4 endonuclease V does not inhibit melanoma formation in Cdk4(R24C\/R24C)\/Tyr-Nras(Q61K) mice following neonatal UVR","volume":"23","author":"Hacker","year":"2010","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/727241","article-title":"Targeted Liposomal Drug Delivery to Monocytes and Macrophages","volume":"2011","author":"Kelly","year":"2011","journal-title":"J. Drug Deliv."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0169-409X(99)00041-1","article-title":"The size of liposomes: A factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs","volume":"40","author":"Nagayasu","year":"1999","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/11\/1146\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:25:51Z","timestamp":1760167551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/11\/11\/1146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,4]]},"references-count":197,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["jpm11111146"],"URL":"https:\/\/doi.org\/10.3390\/jpm11111146","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,4]]}}}